Trials / Suspended
SuspendedNCT04835025
Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer
A Retrospective, Multicenter Case-control Study of Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Retrospective, Multicenter, Controlled Study to Evaluate Immunotherapy and Radiotherpay for Brain Lesions as a Potential Treatment for Patients with Brain Metastasis in non-small cell lung cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PD-1/PD-L1 inhibitor | In non-small cell lung cancer, patients with brain metastases received radiotherapy for brain lesions and immunotherapy (including sequential and concurrent model). Those patients would enter the trial group; After patients experiencing PD in this group, follow-up treatment until tumor progression again or death |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Completion
- 2021-07-31
- First posted
- 2021-04-08
- Last updated
- 2021-04-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04835025. Inclusion in this directory is not an endorsement.